Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy
Titel:
Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy
Auteur:
Billingsley, Caroline C. Jacobson, Samuel N. Crafton, Sarah M. Crim, Aleia K. Li, Quan Hade, Erinn M. Cohn, David E. Fowler, Jeffrey M. Copeland, Larry J. Salani, Ritu Backes, Floor J. O’Malley, David M.